View Profile

Leticia Manen-Freixa

ProCure, Oncobell · IDIBELL

https://researchid.co/lmafrei
@idibell.cat
5Scopus Publications
34Google Scholar Citations
3Google Scholar h-index
1Google Scholar i10-index

Research Interests

Computational Chemistry, Cheminformatics

Biography

Dr. Leticia Manen-Freixa currently holds the position of R&D Scientist in Cheminformatics & Drug Design at IDIBELL, where she also serves as the Computational Lab Manager. This role has provided her with an invaluable opportunity to specialize in a diverse range of areas of Drug Discovery in the oncology R&D field, including polypharmacology, off-target prediction, and the design of antineoplastic drugs. Beyond this, she has delved into the world of artificial intelligence, with a keen focus on Machine Learning, Deep Learning, and NLP. She obtained her PhD in Chemistry and Chemical Engineering from Universitat Ramon Llull in 2022. Her thesis project was positioned in the field of medicinal chemistry, and due to her significant contributions, her profile could be interdisciplinarily described both as a chemoinformatic and organic chemist. She holds a Degree in Chemistry, a MSc in Teacher Training for Secondary School, and a MSc in Pharmaceutical Chemistry.

Education

PhD in Chemistry & Chemical Engineering (IQS School of Engineering - URL) 2018-2022 Master’s Degree in Pharmaceutical Chemistry (IQS School of Engineering - URL) 2017-2018 Master’s Degree in Formation Of Tearchers For Secondary School (UNIR) 2017-2018 Bachelor of Science: Chemistry (IQS School of Engineering - URL) 2012-2016

Recent Scopus Publications

  1. Concurrence of FGFR1 mutations modulates oncogenesis in glioneuronal tumors
    EMBO Journal, 2025
  2. Exploring the unexplored chemical space: Rational identification of new Tafenoquine analogs with antimalarial properties
    Bioorganic Chemistry, 2024
  3. Short-term exposure to environmental levels of nicotine and cotinine impairs visual motor response in zebrafish larvae through a similar mode of action: Exploring the potential role of zebrafish α7 nAChR
    Science of the Total Environment, 2024
  4. Polypharmacology prediction: the long road toward comprehensively anticipating small-molecule selectivity to de-risk drug discovery
    Expert Opinion on Drug Discovery, 2024
  5. Deconstructing Markush: Improving the R&D Efficiency Using Library Selection in Early Drug Discovery
    Pharmaceuticals, 2022

Links